Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man
- PMID: 1175171
Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man
Similar articles
-
Metabolism of methotrexate in man after high and conventional doses.Res Commun Chem Pathol Pharmacol. 1980 Jun;28(3):551-61. Res Commun Chem Pathol Pharmacol. 1980. PMID: 7403667
-
Pharmacokinetics of intermediate dose methotrexate in patients of non-Hodgkin's lymphoma and acute lymphocytic leukaemia.Indian J Cancer. 1980 Sep;17(3):176-8. Indian J Cancer. 1980. PMID: 6936382 No abstract available.
-
Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.Cancer Res. 1982 Sep;42(9):3896-900. Cancer Res. 1982. PMID: 6980707 No abstract available.
-
Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis.J Rheumatol Suppl. 1985 Dec;12 Suppl 12:11-4. J Rheumatol Suppl. 1985. PMID: 3913770 Review.
-
Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion.Drug Metab Rev. 1978;8(1):107-17. doi: 10.3109/03602537808993779. Drug Metab Rev. 1978. PMID: 363377 Review. No abstract available.
Cited by
-
Antineoplastic drugs in 1990. A review (Part II).Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003. Drugs. 1990. PMID: 2191847 Review. No abstract available.
-
Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet. 1987 Mar;12(3):168-213. doi: 10.2165/00003088-198712030-00002. Clin Pharmacokinet. 1987. PMID: 3555940 Review.
-
Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
-
Methotrexate plasma decay kinetics: possible alteration in patients undergoing gut sterilization.Br J Cancer. 1976 Nov;34(5):571-5. doi: 10.1038/bjc.1976.213. Br J Cancer. 1976. PMID: 187211 Free PMC article. No abstract available.
-
Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.Cancer Chemother Pharmacol. 1979;3(3):161-6. doi: 10.1007/BF00262416. Cancer Chemother Pharmacol. 1979. PMID: 316744 No abstract available.